Processing

Please wait...

Settings

Settings

1. US20120035163 - Fused ring compound and use thereof

Office United States of America
Application Number 13142507
Application Date 28.12.2009
Publication Number 20120035163
Publication Date 09.02.2012
Grant Number 08557805
Grant Date 15.10.2013
Publication Kind B2
IPC
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
535
having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
277
Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
02
not condensed with other rings
04
having no double bonds between ring members or between ring members and non-ring members
A61K 31/535
C07D 277/04
CPC
C07D 417/14
A61K 31/427
A61K 31/4439
A61K 31/5377
A61K 31/541
Applicants Yasuma Tsuneo
Takeda Pharmaceutical Company Limited
Takakura Nobuyuki
Miyamoto Yasufumi
Inventors Yasuma Tsuneo
Takakura Nobuyuki
Miyamoto Yasufumi
Agents Wenderoth, Lind & Ponack, L.L.P.
Title
(EN) Fused ring compound and use thereof
Abstract
(EN)

The present invention provides an agent for the prophylaxis or treatment of diabetes, obesity and the like, a glucokinase activator, containing a compound represented by the formula (I):

embedded image
wherein each symbol is as defined in the description, or a salt thereof or a prodrug thereof.